• Skip to main content
  • Go to main navigation
  • Go to language selector
SearchFree text

Swedish Match
SWMA Jul 6, 2022
5:29 PM CET
+ 0.2 % 104.70 SEK
The share
  • svenska
Close
  • Swedish Match websites

    • Image Bank
    • Swedish Match Brasil
    • Swedish Match Industries
    • Snus and Match Museum
  • Brand websites

    Smokefree

    • Swedish Match e-commerce service (SE)
    • Swedish Match e-commerce service (CH)
    • General (US)
    • Longhorn (US)
    • Pinkerton Tobacco
    • ZYN

    Lights

    • Cricket
    • Nitedals
    • Redheads
  • Other

    • Swedish Match Denmark
    • The Solstickan Foundation (SE)
  • Our company More Less

    Our company

    • Our company in brief More Less
      • CEO comment
      • Fact sheet
    • Vision and strategy More Less
      • Financial strategy
      • Sustainability strategy
      • Acquisitions and divestments
    • Markets More Less
      • Our product categories and markets
      • Trends
    • Organization More Less
      • Operating locations
      • Employees
    • Company history More Less
      • Svenska Tobaks AB
      • Svenska Tändsticks AB
      • Swedish Match AB
    • Corporate brand

    CEO comment

  • Our business More Less

    Our business

    • Smokefree More Less
      • Market development More Less
        • Smokefree products in the US
        • Smokefree products in Scandinavia
        • Smokefree products in Other markets
      • Nicotine products and regulations
      • History of snus
      • Snus production
      • Ingredients in snus
    • Cigars More Less
      • Market development
      • History of cigars
    • Lights More Less
      • Market development
    • Risk management
    • Outlook and risk factors

    Snus production

  • Corporate Governance More Less

    Corporate Governance

    • Annual General Meeting More Less
      • Annual General Meeting More Less
        • AGM 2021
        • AGM 2020
        • AGM 2019
      • Nominating Committee
      • AGM address and minutes
      • Dividend and financial policy
      • Auditors
      • Articles of association
    • Committees More Less
      • Remuneration Committee
      • Audit Committee
      • Disclosure Committee
    • Board of Directors More Less
      • About the Board
      • Activities of the Board of Directors
      • Compensation to Board
    • Management More Less
      • About the management
      • Guidelines for executive remuneration
      • Management compensation More Less
        • Incentive plans
    • Insider shareholding
    • Corporate Governance reports More Less
      • Internal control
    Participants at the AGM

    Annual General Meeting

  • Sustainability More Less

    Sustainability

    • Goals and progress
    • Our contribution to the UN SDGs More Less
      • UN SDGs aligned with our focus areas
      • UN SDGs beyond our focus areas
    • Strategy and organization
    • Materiality assessment More Less
      • Other topics outside our focus areas
      • Sustainable Tobacco Program
    • Value chain
    • Code of Conduct More Less
      • Supplier Code of Conduct
    • Focus areas More Less
      • Improve public health
      • Ensure ethical business practices
      • Reduce environmental impact
      • Human rights in our supply chain
      • Equal opportunity
    • Sustainability reporting
    • Sustainability FAQ
    • Sustainability contacts
  • Investors More Less

    Investors

    • The share More Less
      • Per share data
      • Shares outstanding
      • Share capital development
      • Share holdings More Less
        • Largest shareholders
      • Dividend information
      • Analysts and estimates
      • Indicies
    • Share split
    • Follow our journey
    • Calendar
    • Presentations More Less
      • Webcasts and audiocasts
    • Financial reports More Less
      • Interim reports
      • Annual reports More Less
        • Annual report 2021
    • Financial tables More Less
      • Income statement
      • Balance sheet
      • Cash flow analysis
      • By product segment More Less
        • Sales
        • Operating profit
        • Operating margin
      • Key ratios
      • Statement of comprehensive income
    • Debt information More Less
      • Debt sources of financing
      • Debt programs
      • Outstanding bonds
      • Credit rating
      • Financial risks More Less
        • Sensitivity analysis
    • IR contacts
    • Information on cash offer announcement by PMI
  • Media More Less

    Media

    • Press releases and news
    • Images More Less
      • Swedish Match logotype
    • Videos
    • Pressroom
    • Media contacts
  • Snus and health More Less

    Snus and health

    • Our standpoint
    • The Swedish Experience
    • Research on snus
    • Smoking cessation
    • GOTHIATEK® More Less
      • GOTHIATEK® standard
    • Snus and the Swedish Food Act
    • Nicotine More Less
      • Nicotine labeling of Swedish Match products
      • Snus, nicotine and nicotine addiction
    • Tobacco use More Less
      • Tobacco use in figures
    GOTHIATEK® Quality standard

    Swedish Match quality standard

  • Career More Less

    Career

    • Employee strategy
    • Our culture More Less
      • Employee surveys
    • Work environment
    • Diversity and non-discrimination
    • Competence development
    • Compensation and benefits
    • What we do
    • Meet our employees
    • Vacant positions
    • Student
    • HR contacts

    Vacant positions

Our websites
Language:
  • English
  • svenska
Media
  • Press releases and news
  • Images
  • Videos
  • Pressroom
  • Media contacts
Swedish Match's logo
News; May 9, 2007 10:00 AM CET

Lancet: Snus positive for public health

Bans on snus or overstated propaganda against the product are not a sound public-health policy, since cigarette smoking is the overshadowing health problem. This is the conclusion reached in today's issue of the respected medical journal The Lancet.

Today, The Lancet published two scientific studies on the public-health effects of Swedish moist snuff ("snus"). The studies are examined in a leading article by two of the US's most respected tobacco researchers.

Same health gain for smoking cessation with moist snuff

In the Australian study (Gartner et al, 2007) the authors conclude that access to snus would bring substantial public-health gains in countries where the product is not used today. They find, for example, that smoking cessation, whether it is achieved with the aid of snus or by some other means, brings about roughly the same health gains. The authors conclude that this motivates a more positive attitude to snus as an aid to smoking cessation.

Smoking causes major cancer risk, but not snus

The second article contains an analysis of the risk of contracting three smoking-related forms of cancer among participants in the Swedish Construction Worker Survey: lung cancer, oral cavity cancer and cancer of the pancreas (Luo et al, 2007). There was no increase in the incidence of either lung cancer of oral cavity cancer among users of snus. On the other hand, the authors found that there was a doubling of the risk of cancer of the pancreas among non-smoking construction workers who stated that they used snus, compared with those who neither used snus nor smoked cigarettes. However, the risk increase was less for snus than for cigarettes.

Dramatic differences in health risk

The American tobacco researchers Jonathan Foulds and Lynn Kozlowski comment on the Lancet articles in an Editorial. They take the view that the results support the use of snus in countries where smoking is common. They also believe that public-health representatives should give the general public correct information about the dramatic difference in health risks between smoking and snus. The background is that a large percentage of the population in most countries, including Sweden, labor under the misapprehension that the use of smokeless tobacco products, such as snus, involves approximately the same health risks as smoking. They conclude their Editorial by stating that bans on snus or overstated propaganda against it are not sound public-health policy, since cigarette smoking is the overriding health problem.

Significant step for combating smoking

"This is a significant step forward for research on how to combat the harmful effects of smoking," says Lars Erik Rutqvist, medical spokesman for Swedish Match AB, oncologist and former Professor of Oncology at the Karolinska Institute in Stockholm.

"This provides grounds for a more responsible and evidence-based attitude to tobacco-related issues, particularly in Sweden, where the availability of snus has proved to be an effective tool for limiting the harmful effects of smoking, despite vociferous resistance from a small group of aggressive snus opponents," says Rutqvist.

Cancer of the pancreas halved - despite increased use of snus

"It is unlikely that the results regarding cancer of the pancreas from the Swedish Construction Worker Survey are an accurate reflection of the effects of snus," says Freddi Lewin, also a medical spokesman for Swedish Match and oncologist.

"The risk of being affected by this form of cancer has been cut in half in Sweden since the mid-1980s, simultaneously as the use of snus has increased substantially. This suggests that snus, unlike smoking, is not a significant risk factor. There are sources of error in all epidemiological studies, including this one. Swedish results in this area point in different directions, but we naturally welcome all additional knowledge that can help to clarify the issue," concludes Lewin.

References:

Foulds J., Kozlowski L. "Snus - what should the public health response be? The Lancet, online publication, May 10, 2007.

Gartner C. E., Hall W. D., Vos T., et al. "Assessment of Swedish snus for tobacco harm reduction: an epidemiological modeling study. The Lancet, online publication, May 10, 2007.

Luo J., Ye W., Zendehdel K., et al. Oral use of Swedish moist snuff (snus) and risk of cancer of the mouth, lung and pancreas in male construction workers: a retrospective cohort study. The Lancet, online publication, May 10, 2007.

For more information, contact:

Lars Erik Rutqvist, specialist in cancer-related illnesses and former Professor of Oncology, Karolinska Institute, Stockholm Medical spokesman for Swedish Match AB Tel.
+46 8-658 02 43, mobile +46 76-878 84 98, e-mail lars-erik.rutqvist@swedishmatch.com

Related documents

  • Presentations
  • Our company
  • CEO comment
  • Annual General Meeting

Share

Share Facebook Share Twitter Share Linkedin

Share this page by email

Incorrect email
Incorrect email
Home / Media / Press releases and news / Lancet: Snus positive for public health

Contact us

  • IR contacts
  • Media contacts
  • Sustainability contacts
  • HR contacts
  • Consumer contact
  • Web contact

Find us

  • Headquarters
  • Sales office
  • Factory
  • Distribution
  • Store
  • Research & Development
  • All addresses
Map

Corporate headquarters

Phone: +46 10 13 93 000

Sveavägen 44
SE-118 85 Stockholm

Corporate headquarters
Swedish Match

Swedish Match AB
SE-118 85 Stockholm

Phone +46 10 13 93 000
Corporate reg no. 556015-0756
contactus@swedishmatch.com

About the website

  • Sitemap
  • Site policy
  • Privacy notice
  • Information about cookies
  • Legal responsibility

Find information

  • Search
  • FAQ
  • Archive
  • Glossary

Subscription services

  • Subscription service
  • RSS

Follow us

Facebook Twitter Linkedin